Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

HC Wainwright & Co. Downgrades Ortho Clinical Diagnostic to Neutral, Announces $24.68 Price Target

Author: Benzinga Newsdesk | December 27, 2021 06:05am

HC Wainwright & Co. analyst Yi Chen downgrades Ortho Clinical Diagnostic (NASDAQ:OCDX) from Buy to Neutral and announces $24.68 price target.

Posted In: OCDX